The SLU Vaccine and Treatment Evaluation Unit received a five-year, $5.8 million NIH contract to study the safety and efficacy of vaccines using “omics” research techniques to look deeper into how the body’s immune system responds to infections and infectious diseases. These studies aim to develop better and more effective vaccines and treatments for a variety of diseases.
Samples will be analyzed from SLU and other vaccine centers. Under the contract, four different ‘omics areas will be studied and several Biochemistry faculty will participate.
David Ford, Ph.D., Professor of Biochemistry, will analyze the Lipidomics of the immune response. Lipid metabolism pathways produce many metabolites that are involved in multiple biological processes and pathways.
David Wood, Ph.D., Assistant Research Professor of Biochemistry, and Yie-Hwa Chang, Ph.D., Professor of Biochemistry, will analyze the Proteomics of the immune response. The structure and function of various immune system proteins, such as antibodies, will be studied to determine differences in protein structure under varying cell conditions.
For more information, see the story in Newslink.